Kristen Bell Selects the Winners of the Prostate Cancer Foundation’s 3rd Annual True Love Contest
LOS ANGELES, Calif., March 18, 2020 – The Prostate Cancer Foundation (PCF) and actress Kristen Bell announced today, the winners of the 3rd Annual TRUE Love Contest that honors caregivers...Read More
Cleveland Clinic Researchers Validate Link Between Genetic Variant and Poor Outcomes in Men with Advanced Prostate Cancer
February 13, 2020, CLEVELAND: In a new Cleveland Clinic-led study published in JAMA Oncology, researchers show that the a testosterone-related genetic variant – HSD3B1(1245C) – is associated with more aggressive...Read More
The Prostate Cancer Foundation Recruits NBA and NHL Teams to Join Forces for the 2nd Annual PCF Black History Month Assist Challenge
LOS ANGELES, Calif., February 4, 2020 – The Prostate Cancer Foundation (PCF) has drafted teams from the NBA and NHL to help fight prostate cancer with the 2nd Annual PCF...Read More
The Prostate Cancer Foundation and Kristen Bell Honor Caregivers with its 3rd Annual True Love Contest
LOS ANGELES, Calif., January 29, 2020 – Beginning February 1st, the Prostate Cancer Foundation (PCF) will launch its 3rd Annual TRUE Love contest to honor family and caregivers for their...Read More
FDA approves enzalutamide for metastatic castration-sensitive prostate cancer
December 16, 2019 – Today the U.S. Food and Drug Administration (FDA) approved a new use for enzalutamide (Xtandi®) for the treatment of metastatic hormone-sensitive (aka, “castration-sensitive”) prostate cancer (mHSPC). Enzalutamide has...Read More
Winship study sheds light on immune control of cancer
Issued by: Emory University Woodruff Health Sciences Center New findings could provide doctors with vital clues about how the immune system prevents cancer from recurring. The study from Winship Cancer...Read More
The Prostate Cancer Foundation Adds Four New Centers Of Excellence To Serve And Honor Veterans With Prostate Cancer
LOS ANGELES, Calif., Nov. 11, 2019 /PRNewswire/ -- Four new Prostate Cancer Foundation (PCF) Centers of Excellence (COEs) have joined the PCF's dedicated network of centers executing the ambitious mission of improving the...Read More
THE PROSTATE CANCER FOUNDATION ANNOUNCES A COLLABORATIVE GRANTS PROGRAM IN PROSTATE CANCER RESEARCH
LOS ANGELES, Calif., September 26, 2019 – The Prostate Cancer Foundation (PCF) today announced a collaboration with Pfizer Global Medical Grants to fund approximately $2 million in research grants through...Read More
FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer
September 18, 2019 – Last night the U.S. Food and Drug Administration (FDA) approved apalutamide (Erleada) for the treatment of metastatic hormone-sensitive (aka, “castration-sensitive”) prostate cancer (mHSPC). Apalutamide has previously...Read More
The Prostate Cancer Foundation Made History by Lighting U.S. Landmarks “Blue” Across All 50 States to Illuminate Prostate Cancer Issue
LOS ANGELES, Calif., September 4, 2019 – For the first time in American history, U.S. landmarks in all 50 states (and the District of Columbia) were lit blue on September...Read More